ColitisColitis, UlcerativeAntineoplastic Combined Chemotherapy ProtocolsInflammationInflammation MediatorsCytokinesChemotherapy, AdjuvantTumor Necrosis Factor-alphaInterleukin-8LipopolysaccharidesMice, Inbred C57BLColitis, IschemicMacrophagesNF-kappa BInterleukin-6Cells, CulturedToll-Like Receptor 4Toll-Like Receptor 2Dextran SulfateMice, KnockoutColitis, MicroscopicSignal TransductionCombined Modality TherapyAntineoplastic AgentsColitis, CollagenousInterleukin-1betaCisplatinColonIntestinal MucosaMonocytesTrinitrobenzenesulfonic AcidTreatment OutcomeCyclophosphamideDoxorubicinMyeloid Differentiation Factor 88Disease Models, AnimalSeoul virusRNA, MessengerChemokinesInterleukin-10Gene Expression RegulationCell LineInterleukin-1Immunity, InnateToll-Like ReceptorsUp-RegulationEpithelial CellsNeoadjuvant TherapyTime FactorsLungMice, Inbred BALB CReverse Transcriptase Polymerase Chain ReactionColitis, LymphocyticDisease-Free SurvivalEnzyme-Linked Immunosorbent AssayNeutrophilsMicrogliaCrohn DiseaseBreast NeoplasmsChemokine CCL2EtoposideMacrophage ActivationSurvival AnalysisNeoplasm StagingInterferon-gammaPrognosisDrug Administration ScheduleInflammatory Bowel DiseasesSurvival RateNitric Oxide Synthase Type IIDose-Response Relationship, DrugApoptosisLung NeoplasmsGene ExpressionIntercellular Adhesion Molecule-1Toll-Like Receptor 9MethotrexateAnti-Inflammatory AgentsEndothelial Cellsp38 Mitogen-Activated Protein KinasesHMGB1 ProteinMacrophages, PeritonealBlotting, WesternToll-Like Receptor 6Flow CytometryCyclooxygenase 2SepsisAntigens, CD14CarboplatinI-kappa B ProteinsPaclitaxelInduction ChemotherapyDendritic CellsTranscription Factor RelAVinblastineInterleukin-12Cell Line, TumorDown-RegulationMembrane GlycoproteinsChemokine CCL5